In a patient on insulin scheduled for surgery requiring pre‑operative NPO status, when should the rapid‑acting and basal insulin doses be held or reduced?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Perioperative Insulin Management: When to Hold Insulin Before Surgery

For patients on insulin scheduled for surgery, hold all rapid-acting/short-acting (prandial) insulin on the morning of surgery, reduce basal insulin to 75-80% of the usual long-acting analog dose (or 50% of NPH) on the morning of surgery, and reduce the evening basal insulin dose by 25% the night before surgery. 1, 2

Basal Insulin Adjustments

The Night Before Surgery

  • Reduce the evening basal insulin dose by 25% from the usual dose the night before surgery 1, 2
  • This single intervention is the most evidence-based strategy to achieve perioperative glucose targets (100-180 mg/dL) while minimizing hypoglycemia risk, which peaks overnight when 78% of hypoglycemic episodes occur 2

Morning of Surgery

  • Give 75-80% of the usual long-acting basal insulin analog (glargine, detemir, degludec) dose on the morning of surgery 3, 1, 4
  • Give 50% of the usual NPH insulin dose if using intermediate-acting insulin 3, 4
  • Never discontinue basal insulin entirely while NPO—this is a critical error that leads to hyperglycemia and worse perioperative outcomes 2

Rapid-Acting/Short-Acting (Prandial) Insulin

  • Hold all rapid-acting and short-acting insulin on the morning of surgery 3, 1
  • Do not give any prandial insulin doses while the patient is NPO 3, 1
  • Use rapid-acting or short-acting insulin only for correction doses if blood glucose exceeds 180 mg/dL during the NPO period 1, 2

Blood Glucose Monitoring While NPO

  • Monitor blood glucose every 2-4 hours throughout the NPO period, including overnight 1, 2
  • Target range: 100-180 mg/dL (5.6-10.0 mmol/L) 3, 1, 4
  • Administer correction doses of rapid-acting or short-acting insulin when glucose exceeds 180 mg/dL 1, 2

Other Diabetes Medications to Hold

  • Metformin: Hold on the day of surgery (can be taken with dinner the night before) 3, 1, 5
  • SGLT2 inhibitors: Discontinue 3-4 days before surgery due to euglycemic ketoacidosis risk 3, 1, 4
  • All other oral glucose-lowering agents: Hold on the morning of surgery 3, 1

Dextrose Infusion Considerations

  • D5 infusion is NOT routinely necessary for all NPO patients on reduced basal insulin 2
  • Start D5 infusion only if blood glucose falls below 70 mg/dL or is trending downward despite the reduced basal insulin dose 2
  • The 75-80% basal insulin dosing strategy is designed to maintain euglycemia without requiring routine dextrose supplementation 2

Critical Pitfalls to Avoid

Most Common Error

Failing to reduce the basal insulin dose the evening before surgery is the single most critical error, significantly increasing overnight hypoglycemia risk 2

Second Most Common Error

Discontinuing basal insulin entirely while NPO leads to hyperglycemia and increased perioperative complications 2

Third Common Error

Using correction-only ("sliding scale") insulin without basal insulin coverage is associated with poorer glycemic control and higher complication rates in surgical patients 4

Dosing Error

Inappropriately increasing basal insulin to control postprandial hyperglycemia will cause hypoglycemia in the fasting state—basal insulin doses in excess of basal requirements are dangerous when NPO 6

Perioperative Glucose Targets

  • Target range: 100-180 mg/dL (5.6-10.0 mmol/L) throughout the perioperative period 3, 1, 4
  • Stricter targets (<100 mg/dL or 80-180 mg/dL) do not improve outcomes and significantly increase hypoglycemia risk 1, 4
  • For elective surgeries, aim for HbA1c <8% when possible to reduce surgical risk 3, 1, 4

References

Guideline

Perioperative Glucose Management for Patients on Basal Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Perioperative Glucose Management for Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Perioperative Metformin Management for Arthroscopy in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended basal‑bolus insulin regimen, including starting total daily dose, basal‑to‑bolus split, and glucose monitoring, for an adult with type 1 diabetes or a type 2 diabetic uncontrolled on oral agents who can perform multiple daily injections?
Do you dose fast‑acting insulin based on pre‑meal glucose values or on the 2‑hour postprandial glucose reading?
What insulin regimen should be used for a patient requiring 8 units of rapid‑acting insulin during the day and 4 units of basal insulin at night?
What are the recommended timings for basal and rapid‑acting insulin doses in a 70‑kg adult?
What pre‑meal dose of rapid‑acting insulin should be given to a patient taking insulin glargine 15 U once daily with a baseline random blood glucose of 249 mg/dL?
What is the recommended evaluation and management of cervical polyps in women of reproductive age, including indications for removal, removal technique, timing in pregnancy, and follow‑up?
Why does adding Proviron (mesterolone) to my testosterone replacement therapy markedly increase my libido?
Can a mental‑health nurse practitioner prescribe ropinirole (Requip) for restless‑legs syndrome within their scope of practice?
What is the first‑line medication to treat heavy menstrual bleeding (menorrhagia) in an adult woman without contraindications?
A patient taking lisinopril 20 mg daily and nebivolol 5 mg has a blood pressure of 189/115 mm Hg; what are the appropriate next management steps?
What is the recommended amoxicillin regimen for treating susceptible Haemophilus influenzae infections in adults and children, and what alternatives should be used for beta‑lactamase–producing strains or penicillin‑allergic patients?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.